Correlation Between Apellis Pharmaceuticals and Deciphera Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Deciphera Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Deciphera Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apellis Pharmaceuticals and Deciphera Pharmaceuticals LLC, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Deciphera Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Deciphera Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Deciphera Pharmaceuticals.

Diversification Opportunities for Apellis Pharmaceuticals and Deciphera Pharmaceuticals

0.09

Correlation Coefficient

Apellis Pharmaceuticals  Deciphera Pharmaceuticals

Significant diversification

The 3 months correlation between Apellis and Deciphera is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Deciphera Pharmaceuticals LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Deciphera Pharmaceuticals and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Deciphera Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Deciphera Pharmaceuticals has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Deciphera Pharmaceuticals go up and down completely randomly.

Pair Corralation between Apellis Pharmaceuticals and Deciphera Pharmaceuticals

If you would invest  1,332  in Deciphera Pharmaceuticals LLC on September 2, 2024 and sell it today you would earn a total of  0.00  from holding Deciphera Pharmaceuticals LLC or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	1.56%
Values	Daily Returns

Apellis Pharmaceuticals  vs.  Deciphera Pharmaceuticals LLC

Apellis Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Apellis Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Deciphera Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Deciphera Pharmaceuticals LLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Deciphera Pharmaceuticals is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Apellis Pharmaceuticals and Deciphera Pharmaceuticals

The main advantage of trading using opposite Apellis Pharmaceuticals and Deciphera Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Deciphera Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Deciphera Pharmaceuticals will offset losses from the drop in Deciphera Pharmaceuticals' long position.

The idea behind Apellis Pharmaceuticals and Deciphera Pharmaceuticals LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.